Genetically modified rodents and rodent cells, and uses thereof
EP4757593A1Pending Publication Date: 2026-06-17CAMBRIDGE ENTERPRISE LTD
Patent Information
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- CAMBRIDGE ENTERPRISE LTD
- Filing Date
- 2024-08-09
- Publication Date
- 2026-06-17
Smart Images

Figure EP2024072588_13022025_PF_FP_ABST
Abstract
Transgenic rodents and rodent cells that express components of the human immune system, and their uses in generating human T cell receptors (TCRs). A genetically modified rodent comprising a TCR alpha gene locus comprising unrearranged human TCR alpha variable gene segments and a human TCR alpha constant region, and a TCR beta gene locus comprising unrearranged human TCR beta variable gene segments and a human TCR beta constant region. Use of hTCR transgenic rodents to generate antigen-specific CD8+ T cell responses for the discovery of fully human TCR sequences with therapeutic potential.
Need to check novelty before this filing date? Find Prior Art